The Infection Control Today® COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.
November 13th 2024
A 3-D approach to infection control involves air and surface cleaning, leveraging monitoring, purification, and modeling technologies to reduce respiratory infection risks in health care environments.
Risks, Benefits of Receiving a COVID-19 Vaccine: Is it Worth it?
September 12th 2023“Once people started to get infected and reinfected despite being vaccinated, their interpretation then is this vaccine doesn't work…. But [the COVID-19 vaccine] was never designed, studied, tested, or released to protect against infection.” --Ambassador Deborah Birx, MD
Original mRNA Vaccines Helped Protect Children Against COVID-19-Associated ED Visits
September 5th 2023According to a recent Morbidity and Mortality Weekly Report, the original COVID-19 monovalent and bivalent vaccines helped reduce emergency department or urgent care encounters for children aged 6 months to 5 years.
Opinion: Post Pandemic Strategies Are Inadequate To Assure Public Safety
July 13th 2023In his analysis, Kevin Kavanagh, MD, explores the measures taken by the infectious disease sector in response to the pandemic, pointing out both effective and ineffective approaches. He also discusses how the pandemic has affected the treatment of other infectious diseases.
FDA Committee Recommends COVID-19 Vaccines Should Be Monovalent, Contain the XBB Strain
June 19th 2023The FDA committee, known as VRBPAC, in charge of evaluating vaccines and related biological products recently voted unanimously that the upcoming 2023-2024 COVID-19 vaccines should be updated with a monovalent XBB strain.